Reproducibility of defibrillation efficacy for termination of induced ventricular fibrillation using defibrillation threshold energies in patients with implantable cardioverter-defibrillator;Reproduzierbarkeit der defibrillations-effektivitat zur terminierung von induziertem kammerflimmern unter verwendung der intraoperativ gemessenen defibrillations-schwellenenergie bei patienten mit implantierbarem kardioverter-defibrillator

Zeitschrift fur Kardiologie

Volumn 87, Issue 12, 1998, Pages 971-977

  Jung, J ^a   Neuzner, J ^b   Himmrich, E ^c   Vester, E ^d   Michel, U ^e   Fries, R ^a   Pitschner, H ^b   Liebrich, A ^c   Ganschow, U ^d   Heisel, A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e CPI/Guidant   (Belgium)

Author keywords

Defibrillation threshold; Implantable cardioverter defibrillator (ICD); Safety margin

Indexed keywords

ARTICLE; CARDIOVASCULAR SURGERY; DEFIBRILLATION; DEFIBRILLATOR; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; PATIENT MONITORING; RISK ASSESSMENT; TREATMENT OUTCOME; ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EQUIPMENT; FEMALE; HEART PACING; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

ADULT; AGED; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT SAFETY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 0032216778     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050254     Document Type: Article

References (19)

1. Akthar M, Jazayeri M, Sra J, Tchou P, Rovang K, Blanck Z, Dhala A, Deshpande S, Axtell K (1993) Implantable cardioverter/defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation. PACE 16:511-518
2. Böcker D, Block M, Isbruch F, Wietholt D, Hammel D, Borggrefe M, Breithardt G (1993) Do patients with an implantable defibrillator live longer? J Am Coll Cardiol 21:1638-1644
3. Davy JM, Fain ES, Dorian P, Winkle RA (1987) The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the defibrillation threshold concept. Am Heart J 113:77-84
4. Gold MR, Kavesh NG, Peters RW, Shorofsky SR (1997) Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system. J Am Coll Cardiol 30:233-236
5. Hsia HH, Mitra RI, Flores BT, Marchlinksi FE (1994) Early postoperative increase in defibrillation threshold with nonthoracotomy systems in humans. PACE 17: 1166-1173
6. Jones DL, Irish WD, Klein GJ (1991) Defibrillation efficacy: comparison of defibrillation threshold versus dose-response curve determination. Circ Res 69:45-51
7. Kommission für Klinische Kardiologie unter Mitwirkung der Arbeitsgruppe "Interventionelle Elektrophysiologie" der Deutschen Gesellschaft für Herz-und Kreislaufforschung (Hrsg.) bearbeitet von Andresen D, Block M, Borggrefe M, Brachmann J, Goedel-Meinen L, Gonska BD, Hohnloser S, Kuck KH, Kunze KD, Trappe J, Treese N, Volkmann HJ (1994) Empfehlungen zur Implantation von Defibrillatoren. Z Kardiol 83:242-246
8. Lang DJ, KenKnight BH (1994) Implant support devices. In: Singer I (ed.) Implantable Cardioverter/Defibrillator. Futura Publishing Co, Inc. Armonk, New York; pp 223-253
9. Martin DT, John R, Venditti FJ (1995) Increase in defibrillation threshold in nonthoracotomy implantable defibrillators using a biphasic waveform. Am J Cardiol 76: 263-266
10. Mirowski M, Reid P, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML (1980) Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 303:322-324
11. Movsowitz C, Marchlinksi FE (1998) Interactions between implantable cardioverter-defibrillators and class III agents. Am J Cardiol 82:411-481
12. Neuzner J (1996) Safety margins: lessons from the low energy endotak trial (LEET). Am J Cardiol 78 (Suppl 5A):26-32
13. Neuzner J, Pitschner HF, Stöhring R, Reinisch P, Schlepper M (1995) Implantierbare Kardioverter/Defibrillatoren mit endokardialen Elektrodensystemen: Langfristige Stabilität der Defibrillationseffektivität. Z Kardiol 84:44-50
14. Rattes MF, Jones DL, Sharma AD, Klein GJ (1987) Defibrillation threshold: a simple and quantitative estimate of the ability to defibrillate. PACE 10:70-77
15. Schwartzman D, Callans DJ, Gottlieb CD, Heo J, Marchlinksi FE (1996) Early postoperative rise in defibrillation theshold in patients with nonthoracotomy defibrillation lead systems: attenuation with biphasic shock waveforms. J Cardiovasc Electrophysiol 7:483-493
16. Singer I, Lang D (1992) Defibrillation threshold: clinical utility and therapeutic implications. PACE 15:932-949
17. Strickberger SA, Daoud EG, Davidson T, Weiss R, Bogun F, Knight BP, Bahu M, Goyal R, Man KC, Morady F (1997) Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation 96:1217-1223
18. Venditti FJ, Martin DT, Vassolas G, Bowen S (1994) Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator. Circulation 89:216-223
19. Winkle RA, Mead RH, Ruder MA, Gaudani VA, Smith NA, Buch WS, Schmidt P, Shipman T (1989) Long-term outcome in patients receiving an automatic cardioverter/defibrillator. J Am Coll Cardiol 14:508-514